COVID-19 Vaccine Hesitancy in Three Latin American Countries: Reasons Given for Not Becoming Vaccinated in Colombia, Ecuador, and Venezuela
COVID-19 Vaccine Hesitancy in Three Latin American Countries: Reasons Given for Not Becoming Vaccinated in Colombia, Ecuador, and Venezuela
复制标题
DOI：
10.1080/10410236.2022.2035943
复制
发表时间：
2022-02-16
影响因子：
3.9
通讯作者：
Grijalva, Mario J.
中科院分区：
文献类型：
--
作者：
Bates, Benjamin R.;Villegas-Botero, Adriana;Grijalva, Mario J.
尽管已经开发了预防COVID-19的疫苗，但疫苗犹豫是疫苗接种计划的一个重大障碍。大多数关于COVID-19疫苗犹豫的研究都归咎于错误的信息和对这些疫苗的有效性，安全性和副作用的错误陈述。这些研究的优势是在全球北方进行的。尽管拉丁美洲受到COVID-19的重大负面影响，但很少有研究考察那里的COVID-19疫苗犹豫。我们从1，173名委内瑞拉人、厄瓜多尔人和委内瑞拉人的样本中探索了自愿对COVID-19疫苗犹豫不决的原因。总体而言，这三个国家的COVID-19疫苗犹豫率高于理想水平，但大多数COVID-19疫苗犹豫者提供了一个或更少的原因。提出的原因是多种多样的，包括神话和夸张，但也有个人层面的疫苗接种禁忌症和结构性障碍。由于原因的多样性，单一问题的大规模运动不太可能给哥伦比亚、厄瓜多尔和委内瑞拉的COVID-19疫苗犹豫带来大的转变。我们的数据表明，人际沟通，特别是在厄瓜多尔，以及解决结构性问题，特别是在委内瑞拉，可能对疫苗接种产生最大的影响。
Although vaccines have been developed to prevent COVID-19, vaccine hesitancy is a significant barrier for vaccination programs. Most research on COVID-19 vaccine hesitancy has blamed misinformation and misstated concerns about effectiveness, safety, and side effects of these vaccines. The preponderance of these studies has been performed in the Global North. Although Latin American has been substantially and negatively impacted by COVID-19, few studies have examined COVID-19 vaccine hesitancy there. We explored reasons volunteered for COVID-19 vaccine hesitancy from a sample of 1,173 Colombians, Ecuadorians, and Venezuelans. Overall, COVID-19 vaccine hesitancy in these three countries is higher than desirable, but most people who are COVID-19 vaccine hesitant offered one reason or fewer. The reasons offered are diverse, including myths and exaggerations, but also individual-level contraindications for vaccination and structural barriers. Because of the diversity of reasons, single-issue mass campaigns are unlikely to bring about large shifts in COVID-19 vaccine hesitancy in Colombia, Ecuador, and Venezuela. Our data suggest that interpersonal communication, particularly in Ecuador, and addressing structural concerns, particularly in Venezuela, are likely to have the greatest impact on vaccine uptake.